Sixty Plus Mediclaim
New India Assurance · health insurance
“Why waste time say lot word, when few word do trick?”
Senior option, but co-pay and disease sub-limits are important.
- 6.9/10 overall score
- Pricing band: Rs 24k-58k
- Best for: senior-citizens
Key facts
- Score
- 6.9/10
- Pricing
- Rs 24k-58k
- Best for
- senior-citizens
Detailed review
Pros
- Strong feature set for core segment
- Competitive value for most buyers
Cons
- Can be expensive for edge profiles
- Read exclusions before purchase
- Transparent eligibility summary
- Pros and exclusions called out clearly
- Comparable alternatives linked
Hear from people who have used this
“I shortlisted Sixty Plus Mediclaim during renewal and the benefits-to-cost balance felt practical, not flashy. The decision was much easier after comparing exclusions.”
Recent policy buyer · Renewal journey
“For my family use case, Sixty Plus Mediclaim looked stronger once we checked claims process details, not just marketing claims. The checklist approach helped.”
Family coverage buyer · First-time comparison
Hear from experts
“Sixty Plus Mediclaim works best when buyers verify waiting periods and room-rent conditions up front. Fit depends on use case, not headline score alone.”
Insurance advisor perspective
“The right way to evaluate Sixty Plus Mediclaim is to compare total value over 2-3 years, including service quality and claim support clarity.”
Personal finance analyst perspective
Alternatives to compare
| Criteria | Sixty Plus Mediclaim | Yuva Bharat Health Platinum |
|---|---|---|
| Score | 6.9/10 | 7.6/10 |
| Pricing | Rs 24k-58k | Rs 13k-34k |
Swipe horizontally on mobile to compare.
FAQ
Is Sixty Plus Mediclaim good for first-time buyers?
Sixty Plus Mediclaim can work well when its core benefit structure matches your profile and cost threshold.
What should I compare before buying Sixty Plus Mediclaim?
Compare coverage, exclusions, annual cost, service quality, and two close alternatives before deciding.
Get practical updates
Weekly no-fluff finance breakdowns for India.